Zhejiang Shengda Bio-Pharm released an announcement on abnormal fluctuations in stock trading, after an internal review, the company's daily operations are normal, the market environment and industry policies have not undergone major adjustments, the internal production and operation order is normal, and there is no significant information that should have been disclosed but has not been disclosed.
圣达生物：市场环境、行业政策没有发生重大调整
Zhejiang Shengda Bio-Pharm: there have been no major adjustments to the market environment and industry policies.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.